The effects of chlorpromazine and secobarbital under two conditions of reinforcement on the performance of chronic schizophrenic subjects - PubMed (original) (raw)

Clinical Trial

. 1965 Feb 15;7(2):77-88.

doi: 10.1007/BF00403631.

• PMID: 5318925
• DOI: 10.1007/BF00403631

Clinical Trial

The effects of chlorpromazine and secobarbital under two conditions of reinforcement on the performance of chronic schizophrenic subjects

A Latz et al. Psychopharmacologia. 1965.

No abstract available

PubMed Disclaimer

Similar articles

• A research note on some of the critical factors on the dissimilar effects of chlorpromazine and secobarbital on the digit symbol substitution and continuous performance tests.
  Kornetsky C, Orzack MH. Kornetsky C, et al. Psychopharmacologia. 1964 Jul 6;6(1):79-86. doi: 10.1007/BF00710917. Psychopharmacologia. 1964. PMID: 5318645 Clinical Trial. No abstract available.
• Effects of chlorpromazine, secobarbital and sleep deprivation on attention in monkeys.
  Mirsky AF, Bloch S. Mirsky AF, et al. Psychopharmacologia. 1967;10(5):388-99. doi: 10.1007/BF00403979. Psychopharmacologia. 1967. PMID: 4968313 No abstract available.
• On certain psychopharmacological and physiological differences between schizophrenic and normal persons.
  Kornetsky C, Mirsky AF. Kornetsky C, et al. Psychopharmacologia. 1966;8(5):309-18. doi: 10.1007/BF00453508. Psychopharmacologia. 1966. PMID: 5332344 Review. No abstract available.
• Chlorpromazine: direct measurement of differential behavioral effect.
  Hollis JH. Hollis JH. Science. 1968 Mar 29;159(3822):1487-9. doi: 10.1126/science.159.3822.1487. Science. 1968. PMID: 5732492 Clinical Trial.
• Social stimulus factors in drug effects in human subjects.
  Stitzer ML, Griffiths RR, Bigelow GE, Liebson IA. Stitzer ML, et al. NIDA Res Monogr. 1981 Jul;37:130-54. NIDA Res Monogr. 1981. PMID: 6798455 Review. No abstract available.

Cited by

• Auditory flutter fusion as a measure of the actions of centrally acting drugs: modification of the threshold for fusion and the influence of adapting stimuli.
  Besser GM. Besser GM. Br J Pharmacol Chemother. 1967 Jun;30(2):329-40. doi: 10.1111/j.1476-5381.1967.tb02139.x. Br J Pharmacol Chemother. 1967. PMID: 6036413 Free PMC article. Clinical Trial. No abstract available.
• Drug-related test patterns of depressed patients.
  Legg JF, Stiff MP. Legg JF, et al. Psychopharmacology (Berl). 1976 Nov 10;50(2):205-10. doi: 10.1007/BF00430494. Psychopharmacology (Berl). 1976. PMID: 826963 Clinical Trial.
• The effects of daily administration of carphenazine on attention in the schizophrenic patient.
  Orzack MH, Kornetsky C, Freeman H. Orzack MH, et al. Psychopharmacologia. 1967;11(1):31-8. doi: 10.1007/BF00401506. Psychopharmacologia. 1967. PMID: 4876301 Clinical Trial. No abstract available.
• The use of a simple test of attention as a measure of drug effects in schizophrenic patients.
  Kornetsky C. Kornetsky C. Psychopharmacologia. 1972;24(1):99-106. doi: 10.1007/BF00402907. Psychopharmacologia. 1972. PMID: 4622973 No abstract available.
• The residual effects of flurazepam.
  Bond AJ, Lader MH. Bond AJ, et al. Psychopharmacologia. 1973 Sep 28;32(3):223-35. doi: 10.1007/BF00422145. Psychopharmacologia. 1973. PMID: 4762232 Clinical Trial. No abstract available.

References

1. 1. AMA Arch Neurol Psychiatry. 1954 Feb;71(2):227-37 - PubMed
2. 1. J Consult Psychol. 1956 Oct;20(5):343-50 - PubMed
3. 1. AMA Arch Neurol Psychiatry. 1957 Jan;77(1):28-35 - PubMed
4. 1. J Ment Sci. 1959 Jan;105(438):190-8 - PubMed
5. 1. Psychopharmacologia. 1964 Feb 12;5:161-77 - PubMed

Publication types

MeSH terms

Substances